View in EDS PDF Full Text

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.

Saved in:
Bibliographic Details
Title: Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.
Authors: Álvarez N; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Martín A; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Altum Sequencing Co., Madrid, Spain., Dorado S; Altum Sequencing Co., Madrid, Spain.; Computational Science Department, Carlos III University, Madrid, Spain., Colmenares R; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain., Rufián L; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Altum Sequencing Co., Madrid, Spain., Rodríguez M; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Altum Sequencing Co., Madrid, Spain., Giménez A; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain., Carneros L; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain., Sanchez R; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain., Carreño G; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain., Rapado I; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain., Heredia Y; Altum Sequencing Co., Madrid, Spain., Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Medicine, Complutense University of Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain., Barrio S; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Altum Sequencing Co., Madrid, Spain., Ayala R; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Medicine, Complutense University of Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.
Source: Frontiers in immunology [Front Immunol] 2024 Jun 13; Vol. 15, pp. 1252258. Date of Electronic Publication: 2024 Jun 13 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38938565
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Álvarez+N%22">Álvarez N</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martín+A%22">Martín A</searchLink>; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Altum Sequencing Co., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dorado+S%22">Dorado S</searchLink>; Altum Sequencing Co., Madrid, Spain.; Computational Science Department, Carlos III University, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Colmenares+R%22">Colmenares R</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rufián+L%22">Rufián L</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Altum Sequencing Co., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez+M%22">Rodríguez M</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Altum Sequencing Co., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Giménez+A%22">Giménez A</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carneros+L%22">Carneros L</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez+R%22">Sanchez R</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Carreño+G%22">Carreño G</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rapado+I%22">Rapado I</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Heredia+Y%22">Heredia Y</searchLink>; Altum Sequencing Co., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-López+J%22">Martínez-López J</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Medicine, Complutense University of Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Barrio+S%22">Barrio S</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Altum Sequencing Co., Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ayala+R%22">Ayala R</searchLink>; Hematology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Imas12, Madrid, Spain.; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Medicine, Complutense University of Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Jun 13; Vol. 15, pp. 1252258. <i>Date of Electronic Publication: </i>2024 Jun 13 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38938565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1252258
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1252258
    Titles:
      – TitleFull: Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Álvarez N
      – PersonEntity:
          Name:
            NameFull: Martín A
      – PersonEntity:
          Name:
            NameFull: Dorado S
      – PersonEntity:
          Name:
            NameFull: Colmenares R
      – PersonEntity:
          Name:
            NameFull: Rufián L
      – PersonEntity:
          Name:
            NameFull: Rodríguez M
      – PersonEntity:
          Name:
            NameFull: Giménez A
      – PersonEntity:
          Name:
            NameFull: Carneros L
      – PersonEntity:
          Name:
            NameFull: Sanchez R
      – PersonEntity:
          Name:
            NameFull: Carreño G
      – PersonEntity:
          Name:
            NameFull: Rapado I
      – PersonEntity:
          Name:
            NameFull: Heredia Y
      – PersonEntity:
          Name:
            NameFull: Martínez-López J
      – PersonEntity:
          Name:
            NameFull: Barrio S
      – PersonEntity:
          Name:
            NameFull: Ayala R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 06
              Text: 2024 Jun 13
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1